152 related articles for article (PubMed ID: 32739601)
1. Antagonizing serotonin 2A (5-HT
Madden JT; Reyna NC; Pentkowski NS
Drug Alcohol Depend; 2020 Oct; 215():108178. PubMed ID: 32739601
[TBL] [Abstract][Full Text] [Related]
2. Blocking serotonin 2A (5-HT
Madden JT; Reyna NC; Goranson EV; Gonzalez TA; Zavala AR; Pentkowski NS
Behav Brain Res; 2021 Oct; 415():113521. PubMed ID: 34391796
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute treatments with the serotonin 2A antagonist M100907 alone or in combination with the serotonin 2C agonist WAY163909 on methamphetamine self-administration in rhesus monkeys.
Odabas-Geldiay M; Shields H; Berro LF; Rice KC; Howell LL
Drug Alcohol Depend; 2019 Jan; 194():252-256. PubMed ID: 30469095
[TBL] [Abstract][Full Text] [Related]
4. M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.
Ray A; Canal CE; Ehlen JC; Rice KC; Murnane KS
Neurotoxicology; 2019 Sep; 74():91-99. PubMed ID: 31163210
[TBL] [Abstract][Full Text] [Related]
5. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.
Mirjana C; Baviera M; Invernizzi RW; Balducci C
Neuropsychopharmacology; 2004 Sep; 29(9):1637-47. PubMed ID: 15127084
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
Nawata Y; Yamaguchi T; Fukumori R; Yamamoto T
Int J Neuropsychopharmacol; 2019 Feb; 22(2):165-172. PubMed ID: 30481332
[TBL] [Abstract][Full Text] [Related]
7. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
Calcagno E; Carli M; Baviera M; Invernizzi RW
J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357
[TBL] [Abstract][Full Text] [Related]
8. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Varty GB; Bakshi VP; Geyer MA
Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
[TBL] [Abstract][Full Text] [Related]
9. Effects of cannabinoid CB₁ receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice.
Yu LL; Zhou SJ; Wang XY; Liu JF; Xue YX; Jiang W; Lu L
Behav Brain Res; 2011 Feb; 217(1):111-6. PubMed ID: 20937331
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
Fletcher PJ; Grottick AJ; Higgins GA
Neuropsychopharmacology; 2002 Oct; 27(4):576-86. PubMed ID: 12377394
[TBL] [Abstract][Full Text] [Related]
11. A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
Sun L; Song R; Chen Y; Yang RF; Wu N; Su RB; Li J
Acta Pharmacol Sin; 2016 Feb; 37(2):157-65. PubMed ID: 26687935
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular microinjection of the 5-HT
Shahidi S; Sadeghian R; Komaki A; Asl SS
Pharmacol Biochem Behav; 2018 Oct; 173():27-35. PubMed ID: 30077744
[TBL] [Abstract][Full Text] [Related]
13. The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
Semenova S; Markou A
Eur Neuropsychopharmacol; 2010 Oct; 20(10):731-46. PubMed ID: 20627663
[TBL] [Abstract][Full Text] [Related]
14. M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain.
Habara T; Hamamura T; Miki M; Ohashi K; Kuroda S
Eur J Pharmacol; 2001 Apr; 417(3):189-94. PubMed ID: 11334850
[TBL] [Abstract][Full Text] [Related]
15. Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
Benaliouad F; Kapur S; Rompré PP
Neuropsychopharmacology; 2007 Mar; 32(3):551-61. PubMed ID: 16794561
[TBL] [Abstract][Full Text] [Related]
16. The Effects of 4-Methylethcathinone on Conditioned Place Preference, Locomotor Sensitization, and Anxiety-Like Behavior: A Comparison with Methamphetamine.
Xu P; Qiu Y; Zhang Y; Βai Y; Xu P; Liu Y; Kim JH; Shen HW
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26612552
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of CCL7 and CCL2 in reward system mediated through dopamine D1 receptor signaling underlies methamphetamine-induced place preference in mice.
Saika F; Kiguchi N; Wakida N; Kobayashi D; Fukazawa Y; Matsuzaki S; Kishioka S
Neurosci Lett; 2018 Feb; 665():33-37. PubMed ID: 29174638
[TBL] [Abstract][Full Text] [Related]
18. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats.
Zakharova E; Leoni G; Kichko I; Izenwasser S
Behav Brain Res; 2009 Mar; 198(1):45-50. PubMed ID: 18996417
[TBL] [Abstract][Full Text] [Related]
20. Repeated restraint stress reduces the acquisition and relapse of methamphetamine-conditioned place preference but not behavioral sensitization.
Seo JY; Ko YH; Ma SX; Lee BR; Lee SY; Jang CG
Brain Res Bull; 2018 May; 139():99-104. PubMed ID: 29421246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
